Skip to content
PubMed This is a summary of 79 peer-reviewed journal articles Updated
Nephrology

IgA Nephropathy: A Patient Guide

At a Glance

IgA nephropathy is an immune condition in which altered IgA forms deposits in the kidney filters, causing inflammation and sometimes scarring. Because its course varies, urine tests, kidney-function checks, blood-pressure control, lifestyle changes, and treatment can help protect kidney health.

IgA Nephropathy (IgAN) is a chronic autoimmune condition involving the kidneys’ filtering system. In a healthy body, an antibody called IgA acts as a first line of defense against infections in your throat and gut. However, in people with IgAN, the body produces an altered version of this protein. Your immune system recognizes this altered protein as abnormal, creating autoantibodies that lock onto it. This forms clusters or “immune complexes” in your bloodstream. As your blood circulates through your kidneys, these complexes become trapped in the glomeruli—the tiny, delicate filters that clean your blood—triggering a cycle of inflammation and potential scarring [1][2].

The way this disease behaves is famously unpredictable and varies significantly from person to person. For many, the condition remains “silent” and stable for years, only revealing itself through microscopic traces of blood or protein found during a routine urine test. For others, the disease makes itself known through visible “flares,” where the urine may turn a dark tea or cola color shortly after a sore throat or respiratory infection. While many individuals maintain stable kidney function over their lifetimes, some experience a gradual decline that requires careful, long-term medical management to prevent advanced kidney damage [1][3].

Modern management of IgA Nephropathy focuses on an individualized strategy designed to protect the kidneys at every stage. This approach begins with a strong foundation of supportive care, which includes managing blood pressure and making dietary adjustments to reduce physical stress on the kidney filters. If these foundational steps are not enough to quiet the inflammation and lower urine protein levels, your care team may discuss a growing number of targeted therapies. These treatments—ranging from specialized blood pressure medications to targeted steroids—aim to interrupt the immune process or reduce kidney pressure, offering new ways to slow the progression of the disease [1][4].

Navigating a diagnosis of IgAN means entering into a long-term partnership with your healthcare team. Because the disease often moves slowly, there is time to monitor your lab trends, adjust your treatments, and find the right balance for your lifestyle. By focusing on consistent monitoring and early intervention, you can take an active role in protecting your kidney function and maintaining your overall well-being [5][6].

Common questions in this guide

What is IgA nephropathy, and what happens in the kidneys?
A person with IgA nephropathy produces an altered form of the antibody IgA. The immune system can form complexes with it, and these may lodge in the kidney’s tiny filters, called glomeruli, causing inflammation and possible scarring.
Can IgA nephropathy cause dark or cola-colored urine?
Yes. A flare can cause visible blood in the urine, sometimes making it look dark tea- or cola-colored, particularly soon after a sore throat or respiratory infection.
How do doctors monitor IgA nephropathy over time?
Care teams use urine tests to look for blood and protein and follow lab trends related to kidney function. They also manage blood pressure and adjust care based on whether findings are stable or changing.
Does IgA nephropathy always get worse?
No. Its course is unpredictable: some people have stable kidney function for years, while others have gradual decline and risk advanced kidney damage. Regular monitoring can help the care team identify changes and adjust treatment.
What treatments may protect the kidneys in IgA nephropathy?
Treatment is individualized and usually begins with supportive care, including blood pressure management and dietary adjustments. If these steps do not sufficiently reduce inflammation or urine protein, the care team may discuss specialized blood pressure medicines or targeted steroids.
What lifestyle steps can I take to support my kidneys?
Follow the dietary plan recommended by your healthcare team, use prescribed treatments as directed, and keep scheduled monitoring visits. Ask which changes fit your blood pressure, urine findings, kidney function, and lifestyle because recommendations need to be individualized.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Immunoglobulin A nephropathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How does the 'clumping' of IgA in my kidneys affect my long-term kidney function?
  2. 2.Based on my lab trends, is my disease currently considered stable or active?
  3. 3.What are the most important lifestyle changes I can make right now to support my kidneys?
  4. 4.What specific symptoms or changes should prompt me to call the clinic between scheduled visits?

References

References (6)
  1. 1

    IgA Nephropathy in Adults: A Review.

    Stoneman S, Teh JW, O'Shaughnessy MM

    JAMA 2026; (335(9)):799-813 doi:10.1001/jama.2025.25020.

    PMID: 41587026
  2. 2

    Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don't Know.

    Ohyama Y, Renfrow MB, Novak J, Takahashi K

    Journal of clinical medicine 2021; (10(16)) doi:10.3390/jcm10163467.

    PMID: 34441764
  3. 3

    Epidemiology of IgA Nephropathy: A Global Perspective.

    Schena FP, Nistor I

    Seminars in nephrology 2018; (38(5)):435-442 doi:10.1016/j.semnephrol.2018.05.013.

    PMID: 30177015
  4. 4

    IgA Nephropathy: Mechanisms, Risk Stratification, and Precision Therapy.

    Alobaidi S

    Diagnostics (Basel, Switzerland) 2026; (16(9)) doi:10.3390/diagnostics16091259.

    PMID: 42121963
  5. 5

    Advances in Novel Biologics Targeting BAFF/APRIL in the Treatment of IgA Nephropathy.

    Xu Y, Mo Y, Xu Y

    Cells 2026; (15(3)) doi:10.3390/cells15030240.

    PMID: 41677607
  6. 6

    Evaluating a New International Risk-Prediction Tool in IgA Nephropathy.

    Barbour SJ, Coppo R, Zhang H, et al.

    JAMA internal medicine 2019; (179(7)):942-952 doi:10.1001/jamainternmed.2019.0600.

    PMID: 30980653

This page is for informational purposes only and does not constitute medical advice. A nephrologist or other healthcare professional can interpret your urine tests, kidney function, and treatment options for your situation.